Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess. | Canada Hyperbarics Skip to main content
Clinical Study Clinical and experimental nephrology 2011

Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess.

Vega J, Goecke H, Manriquez F, Escobar C, Escobar M, Videla C, et al. — Clinical and experimental nephrology, 2011

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers described the successful use of hyperbaric oxygen therapy to treat a severe, antibiotic-resistant perinephritic abscess in a 68-year-old patient with autosomal dominant polycystic kidney disease.

What They Found

The patient, who had been febrile and septic for three weeks despite multiple antibiotic regimens, underwent 26 daily sessions of 100% hyperbaric oxygen at 2.5 atm. This therapy led to a notable improvement, and she was discharged after day 58 without signs of inflammatory activity or infection reactivation.

Canadian Relevance

This study has no direct Canadian connection as it was conducted outside of Canada.

Study Limitations

As a single case report, the findings cannot be generalized to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 20886361
Year Published 2011
Journal Clinical and experimental nephrology
MeSH Terms Abscess; Aged; Bacterial Infections; Female; Humans; Hyperbaric Oxygenation; Perinephritis; Polycystic Kidney, Autosomal Dominant; Renal Dialysis; Treatment Outcome

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology